
北美生物防御市场到 2027 年 - 北美生物防御市场到 2027 年的区域分析和预测 - 按产品(炭疽、天花、肉毒杆菌、辐射/核、其他)进行区域分析和预测;和国家
No. of Pages: 134 | Report Code: TIPRE00009997 | Category: Life Sciences
No. of Pages: 134 | Report Code: TIPRE00009997 | Category: Life Sciences
北美生物防御市场预计将从 2019 年的 15.6929 亿美元增至 2027 年的 33.5783 亿美元。该市场预计将以 10.1% 的复合年增长率增长2020-2027。
生物防御市场的增长主要是由于有利的政府举措的存在以及自然发生的疫情数量的增加。生物防御组织的影响范围有限等限制因素可能会损害未来几年市场的增长。另一方面,技术的不断采用预计将对未来几年北美生物防御市场的增长产生积极影响。
<疾病暴发通常由感染引起,通过人与人之间、动物与人之间的接触、或者从环境或其他介质传播。新发传染病是最近在人群中出现并且正在迅速增加或有可能很快增加的感染。世界卫生组织在 2007 年的报告中警告说,传染病正在以前所未有的速度出现。自 20 世纪 70 年代以来,已发现约 40 种传染病,包括 SARS、MERS、埃博拉、禽流感、猪流感、寨卡病毒以及最近的冠状病毒。此外,据美国疾病控制与预防中心估计,2016年至2017年间,美国有近3000万人感染流感。有助于将患病率减少 17%,就诊次数和住院次数分别减少 18% 至 19%。埃博拉和寨卡病毒感染的日益流行也可能有助于市场的发展。例如,由于冠状病毒的爆发,截至 2020 年 3 月 20 日,已向世界卫生组织报告了超过 21 万例病例,超过 9,000 人丧生。此外,2020 年 3 月 18 日,Emergent BioSolutions 与 Vaxart 签署了开发和制造协议用于冠状病毒疾病的实验性口服候选疫苗。
炭疽或天花等病原体、生物毒素、化学武器等的释放神经毒气或放射性物质过去曾造成公众威胁。为了防止此类疫情的爆发,政府制定了各种策略,例如,美国国立卫生研究院支持传染病和生物防御研究,建立并维护有关传染病和免疫相关疾病的基础知识基础,并利用这些知识开发新的和改进诊断、治疗和预防措施,包括疫苗。
冠状病毒埃博拉和寨卡病毒等传染病的日益流行可能会增加该领域的投资
2019年,美国占据北美生物防御市场最大的市场份额,预计在预测期内将以更快的速度增长。美国是一个经济发达国家,该国在生物技术市场上拥有众多成熟的参与者。美国军事和民事机构为生物防御提供的大量资金也是该地区收入份额最高的关键因素之一。因此,考虑到上述因素,预计美国生物防御市场在预测期内将大幅增长。
北美透明矫正器 -市场细分
按地理位置
公司简介
Strategic insights for North America Biodefense involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 1,569.29 Million |
Market Size by 2027 | US$ 3,357.83 Million |
Global CAGR (2020 - 2027) | 10.1% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Biodefense refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - North America Biodefense Market
The North America Biodefense Market is valued at US$ 1,569.29 Million in 2019, it is projected to reach US$ 3,357.83 Million by 2027.
As per our report North America Biodefense Market, the market size is valued at US$ 1,569.29 Million in 2019, projecting it to reach US$ 3,357.83 Million by 2027. This translates to a CAGR of approximately 10.1% during the forecast period.
The North America Biodefense Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Biodefense Market report:
The North America Biodefense Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Biodefense Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Biodefense Market value chain can benefit from the information contained in a comprehensive market report.